Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on BioRestorative concludes Phase II BRTX-100 trial enrolment for cLDD - Clinical Trials Arena

BioRestorative concludes Phase II BRTX-100 trial enrolment for cLDD  Clinical Trials Arena

BioRestorative concludes Phase II BRTX-100 trial enrolment for cLDD - Clinical Trials Arena

Click here to get full coverage on BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Profit Outlook - simplywall.st

BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Profit Outlook  simplywall.st

BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Profit Outlook - simplywall.st

Click here to get full coverage on BioRestorative eyes early back-pain stem cell use in four US states - Stock Titan

BioRestorative eyes early back-pain stem cell use in four US states  Stock Titan

BioRestorative eyes early back-pain stem cell use in four US states - Stock Titan

Click here to get full coverage on BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease - Yahoo Finance

BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease  Yahoo Finance

BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease - Yahoo Finance

Click here to get full coverage on BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease - Ortho Spine News

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease  Ortho Spine News

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease - Ortho Spine News

Click here to get full coverage on BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 - ChartMill

BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026  ChartMill

BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 - ChartMill

Click here to get full coverage on Australia clears patent for cell therapy touted as GLP-1 alternative - Stock Titan

Australia clears patent for cell therapy touted as GLP-1 alternative  Stock Titan

Australia clears patent for cell therapy touted as GLP-1 alternative - Stock Titan

Click here to get full coverage on BioRestorative concludes Phase II BRTX-100 trial enrolment for cLDD - Yahoo Finance

BioRestorative concludes Phase II BRTX-100 trial enrolment for cLDD  Yahoo Finance

BioRestorative concludes Phase II BRTX-100 trial enrolment for cLDD - Yahoo Finance

Click here to get full coverage on BioRestorative Therapies, Inc. to Participate in the - GlobeNewswire

BioRestorative Therapies, Inc. to Participate in the  GlobeNewswire

BioRestorative Therapies, Inc. to Participate in the - GlobeNewswire

Click here to get full coverage on Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data - Ortho Spine News

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data  Ortho Spine News

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data - Ortho Spine News

Click here to get full coverage on BioRestorative (NASDAQ: BRTX) amendment shows no beneficial ownership by filer - Stock Titan

BioRestorative (NASDAQ: BRTX) amendment shows no beneficial ownership by filer  Stock Titan

BioRestorative (NASDAQ: BRTX) amendment shows no beneficial ownership by filer - Stock Titan

Click here to get full coverage on Breakeven On The Horizon For BioRestorative Therapies, Inc. (NASDAQ:BRTX) - Yahoo Finance

Breakeven On The Horizon For BioRestorative Therapies, Inc. (NASDAQ:BRTX)  Yahoo Finance

Breakeven On The Horizon For BioRestorative Therapies, Inc. (NASDAQ:BRTX) - Yahoo Finance

Click here to get full coverage on FDA meeting outlines expedited approval path for BioRestorative BRTX-100 - Stock Titan

FDA meeting outlines expedited approval path for BioRestorative BRTX-100  Stock Titan

FDA meeting outlines expedited approval path for BioRestorative BRTX-100 - Stock Titan

Click here to get full coverage on BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update  Yahoo Finance

BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

Click here to get full coverage on BioRestorative signs up 99 in chronic lumbar disc disease cell therapy trial - Stock Titan

BioRestorative signs up 99 in chronic lumbar disc disease cell therapy trial  Stock Titan

BioRestorative signs up 99 in chronic lumbar disc disease cell therapy trial - Stock Titan

Click here to get full coverage on Stem cell firm BioRestorative raises $5M for trials and R&D - Stock Titan

Stem cell firm BioRestorative raises $5M for trials and R&D  Stock Titan

Stem cell firm BioRestorative raises $5M for trials and R&D - Stock Titan

Click here to get full coverage on Auctus discloses 9.9% BioRestorative (BRTX) ownership in Schedule 13G/A - Stock Titan

Auctus discloses 9.9% BioRestorative (BRTX) ownership in Schedule 13G/A  Stock Titan

Auctus discloses 9.9% BioRestorative (BRTX) ownership in Schedule 13G/A - Stock Titan

Click here to get full coverage on Market Movers | Winners: HCTI, ATPC, ANY | Losers: QVCGA, BRTX, IVDA - Trefis

Market Movers | Winners: HCTI, ATPC, ANY | Losers: QVCGA, BRTX, IVDA  Trefis

Market Movers | Winners: HCTI, ATPC, ANY | Losers: QVCGA, BRTX, IVDA - Trefis

Click here to get full coverage on BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy - Bitget

BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy  Bitget

BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy - Bitget

Click here to get full coverage on BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease - GlobeNewswire

BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease  GlobeNewswire

BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease - GlobeNewswire

Click here to get full coverage on BioRestorative Announces Pricing of $5.0 Million Public Offering - GlobeNewswire

BioRestorative Announces Pricing of $5.0 Million Public Offering  GlobeNewswire

BioRestorative Announces Pricing of $5.0 Million Public Offering - GlobeNewswire

Click here to get full coverage on BioRestorative Expands Global Protection for ThermoStem®, a - GlobeNewswire

BioRestorative Expands Global Protection for ThermoStem®, a  GlobeNewswire

BioRestorative Expands Global Protection for ThermoStem®, a - GlobeNewswire

Click here to get full coverage on BRTX Technical Analysis & Price Forecast - Intellectia AI

BRTX Technical Analysis & Price Forecast  Intellectia AI

BRTX Technical Analysis & Price Forecast - Intellectia AI

Click here to get full coverage on BRTX Stock Price, News & Analysis | Biorestorative Therapies - Stock Titan

BRTX Stock Price, News & Analysis | Biorestorative Therapies  Stock Titan

BRTX Stock Price, News & Analysis | Biorestorative Therapies - Stock Titan

Click here to get full coverage on BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update - Ortho Spine News

BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update  Ortho Spine News

BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update - Ortho Spine News

Click here to get full coverage on BioRestorative Therapies’ MSC Therapy BRTX-100 Fast Tracked for Chronic Lumbar Disc Disease - CGTLive®

BioRestorative Therapies’ MSC Therapy BRTX-100 Fast Tracked for Chronic Lumbar Disc Disease  CGTLive®

BioRestorative Therapies’ MSC Therapy BRTX-100 Fast Tracked for Chronic Lumbar Disc Disease - CGTLive®

Click here to get full coverage on Full Alliance Group (OTC: FAGI) Multi-Division Ecosystem Future Giant Spotlight to Watch Among BRTX, RNWF, DXST, ELPW, Now! - Barchart.com

Full Alliance Group (OTC: FAGI) Multi-Division Ecosystem Future Giant Spotlight to Watch Among BRTX, RNWF, DXST, ELPW, Now!  Barchart.com

Full Alliance Group (OTC: FAGI) Multi-Division Ecosystem Future Giant Spotlight to Watch Among BRTX, RNWF, DXST, ELPW, Now! - Barchart.com

Click here to get full coverage on BRTX Forecast — Price Prediction for 2026. Should I Buy BRTX? - Intellectia AI

BRTX Forecast — Price Prediction for 2026. Should I Buy BRTX?  Intellectia AI

BRTX Forecast — Price Prediction for 2026. Should I Buy BRTX? - Intellectia AI

Click here to get full coverage on BioRestorative Announces Pricing Of $5.0 Million Public Offering - TradingView

BioRestorative Announces Pricing Of $5.0 Million Public Offering  TradingView

BioRestorative Announces Pricing Of $5.0 Million Public Offering - TradingView

Click here to get full coverage on Biorestorative Announces Positive Outcome From Type B Meeting With FDA - TradingView

Biorestorative Announces Positive Outcome From Type B Meeting With FDA  TradingView

Biorestorative Announces Positive Outcome From Type B Meeting With FDA - TradingView

Click here to get full coverage on BioRestorative Therapies issues letter to shareholders - TipRanks

BioRestorative Therapies issues letter to shareholders  TipRanks

BioRestorative Therapies issues letter to shareholders - TipRanks

Click here to get full coverage on BioRestorative Therapies stock plunges after $5 million public offering - Investing.com

BioRestorative Therapies stock plunges after $5 million public offering  Investing.com

BioRestorative Therapies stock plunges after $5 million public offering - Investing.com

Click here to get full coverage on FDA Grants Fast Track Designation to BRTX-100 to Treat Chronic Lumbar Disc Disease - Pharmacy Times

FDA Grants Fast Track Designation to BRTX-100 to Treat Chronic Lumbar Disc Disease  Pharmacy Times

FDA Grants Fast Track Designation to BRTX-100 to Treat Chronic Lumbar Disc Disease - Pharmacy Times

Click here to get full coverage on 12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session  Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Click here to get full coverage on BioRestorative Therapies closes $5 million public offering - Investing.com

BioRestorative Therapies closes $5 million public offering  Investing.com

BioRestorative Therapies closes $5 million public offering - Investing.com

Click here to get full coverage on 12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session  Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Click here to get full coverage on BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Shift From Loss To Profit - Yahoo Finance

BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Shift From Loss To Profit  Yahoo Finance

BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Shift From Loss To Profit - Yahoo Finance

Click here to get full coverage on 12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session  Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Click here to get full coverage on BioRestorative prices $5M stock offering - MSN

BioRestorative prices $5M stock offering  MSN

BioRestorative prices $5M stock offering - MSN

Click here to get full coverage on BRTX Stock Price and Chart — NASDAQ:BRTX - TradingView

BRTX Stock Price and Chart — NASDAQ:BRTX  TradingView

BRTX Stock Price and Chart — NASDAQ:BRTX - TradingView

Click here to get full coverage on Stem Cell Therapy Gets Fast Track Status for Chronic Lumbar Disc Disease - Clinical Pain Advisor

Stem Cell Therapy Gets Fast Track Status for Chronic Lumbar Disc Disease  Clinical Pain Advisor

Stem Cell Therapy Gets Fast Track Status for Chronic Lumbar Disc Disease - Clinical Pain Advisor

Click here to get full coverage on BioRestorative completes patient enrollment in Phase 2 trial of BTRX-100 - TipRanks

BioRestorative completes patient enrollment in Phase 2 trial of BTRX-100  TipRanks

BioRestorative completes patient enrollment in Phase 2 trial of BTRX-100 - TipRanks

Click here to get full coverage on BRTX - Biorestorative Therapies Inc Latest Stock News & Market Updates - Stock Titan

BRTX - Biorestorative Therapies Inc Latest Stock News & Market Updates  Stock Titan

BRTX - Biorestorative Therapies Inc Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on BioRestorative to commence Phase II trial of BRTX-100 in degenerative disc disease - Clinical Trials Arena

BioRestorative to commence Phase II trial of BRTX-100 in degenerative disc disease  Clinical Trials Arena

BioRestorative to commence Phase II trial of BRTX-100 in degenerative disc disease - Clinical Trials Arena

Click here to get full coverage on BioRestorative Therapies (BRTX) Price Target Increased by 19.05% to 12.75 - Nasdaq

BioRestorative Therapies (BRTX) Price Target Increased by 19.05% to 12.75  Nasdaq

BioRestorative Therapies (BRTX) Price Target Increased by 19.05% to 12.75 - Nasdaq

Click here to get full coverage on BRTX Forecast — Price Target — Prediction for 2027 - TradingView

BRTX Forecast — Price Target — Prediction for 2027  TradingView

BRTX Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on Insider Buying Alert: Lance Alstodt Acquires 4200 Shares of BioRestorative Therapies Inc (BRTX) - Yahoo Finance

Insider Buying Alert: Lance Alstodt Acquires 4200 Shares of BioRestorative Therapies Inc (BRTX)  Yahoo Finance

Insider Buying Alert: Lance Alstodt Acquires 4200 Shares of BioRestorative Therapies Inc (BRTX) - Yahoo Finance

Click here to get full coverage on BioRestorative partners with Galen Patient Recruitment for BRTX-100 trial - TipRanks

BioRestorative partners with Galen Patient Recruitment for BRTX-100 trial  TipRanks

BioRestorative partners with Galen Patient Recruitment for BRTX-100 trial - TipRanks

Click here to get full coverage on BioRestorative Therapies (NASDAQ:BRTX) - intelligentinvestor.com.au

BioRestorative Therapies (NASDAQ:BRTX)  intelligentinvestor.com.au

BioRestorative Therapies (NASDAQ:BRTX) - intelligentinvestor.com.au

Click here to get full coverage on Bertinity price today, BRTX to USD live price, marketcap and chart - CoinMarketCap

Bertinity price today, BRTX to USD live price, marketcap and chart  CoinMarketCap

Bertinity price today, BRTX to USD live price, marketcap and chart - CoinMarketCap

Click here to get full coverage on BioRestorative Therapies maintains its 'Buy' rating and $15 target price - Investing.com

BioRestorative Therapies maintains its 'Buy' rating and $15 target price  Investing.com

BioRestorative Therapies maintains its 'Buy' rating and $15 target price - Investing.com

Click here to get full coverage on BioResorative CEO is Featured in An Interview With SmallCaps Daily - Yahoo Finance

BioResorative CEO is Featured in An Interview With SmallCaps Daily  Yahoo Finance

BioResorative CEO is Featured in An Interview With SmallCaps Daily - Yahoo Finance

Click here to get full coverage on BioRestorative Therapies Announces Clinical Site Initiation - GlobeNewswire

BioRestorative Therapies Announces Clinical Site Initiation  GlobeNewswire

BioRestorative Therapies Announces Clinical Site Initiation - GlobeNewswire

Click here to get full coverage on Should I buy Biorestorative Therapies (BRTX) - Zacks Investment Research

Should I buy Biorestorative Therapies (BRTX)  Zacks Investment Research

Should I buy Biorestorative Therapies (BRTX) - Zacks Investment Research

Click here to get full coverage on BioRestorative Therapies Reports Positive Findings from Independent Review of its BRTX-100 Program - GlobeNewswire

BioRestorative Therapies Reports Positive Findings from Independent Review of its BRTX-100 Program  GlobeNewswire

BioRestorative Therapies Reports Positive Findings from Independent Review of its BRTX-100 Program - GlobeNewswire

Click here to get full coverage on Nickolay V. Kukekov Net Worth (2026) - GuruFocus

Nickolay V. Kukekov Net Worth (2026)  GuruFocus

Nickolay V. Kukekov Net Worth (2026) - GuruFocus

Click here to get full coverage on BioRestorative Therapies Announces the Appointment of Adam - GlobeNewswire

BioRestorative Therapies Announces the Appointment of Adam  GlobeNewswire

BioRestorative Therapies Announces the Appointment of Adam - GlobeNewswire

Click here to get full coverage on BioRestorative Therapies, Inc. (BRTX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex

BioRestorative Therapies, Inc. (BRTX) Stock Forecast & Price Prediction 2026–2030  CoinCodex

BRTX

Price Chart

Key Statistics

Technicals

About BRTX

Latest News

symbol__ Stock Quote Price and Forecast - CNN

BioRestorative concludes Phase II BRTX-100 trial enrolment for cLDD - Clinical Trials Arena

BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Profit Outlook - simplywall.st

Advanced Charts

Top Gainers

Top Losers